BOTTI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 8.411
AS - Asia 1.391
EU - Europa 1.066
SA - Sud America 220
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 11.111
Nazione #
US - Stati Uniti d'America 8.373
SG - Singapore 598
CN - Cina 393
HK - Hong Kong 191
BR - Brasile 181
IE - Irlanda 179
DE - Germania 178
IT - Italia 173
UA - Ucraina 122
RU - Federazione Russa 108
KR - Corea 62
FR - Francia 61
GB - Regno Unito 58
VN - Vietnam 54
SE - Svezia 51
PL - Polonia 46
FI - Finlandia 26
CA - Canada 22
IN - India 21
BE - Belgio 18
AR - Argentina 14
JP - Giappone 14
BD - Bangladesh 13
MX - Messico 12
ES - Italia 10
EC - Ecuador 9
NL - Olanda 9
AT - Austria 8
TR - Turchia 8
ID - Indonesia 6
IQ - Iraq 5
KG - Kirghizistan 5
ZA - Sudafrica 5
CO - Colombia 4
CZ - Repubblica Ceca 4
EU - Europa 4
MA - Marocco 4
UZ - Uzbekistan 4
CL - Cile 3
JO - Giordania 3
KE - Kenya 3
PY - Paraguay 3
RS - Serbia 3
VE - Venezuela 3
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
IL - Israele 2
LT - Lituania 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
VC - Saint Vincent e Grenadine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CH - Svizzera 1
GR - Grecia 1
IR - Iran 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 11.111
Città #
Wilmington 1.814
Houston 1.789
Woodbridge 1.411
Fairfield 489
Chandler 422
Singapore 323
Ann Arbor 295
Ashburn 258
Seattle 222
Beijing 199
Hong Kong 185
Cambridge 176
Dublin 164
Medford 124
Dearborn 119
New York 95
Jacksonville 82
Rome 67
The Dalles 62
Santa Clara 60
Lawrence 58
Los Angeles 54
Dallas 39
Kraków 35
Munich 31
Moscow 30
San Diego 30
São Paulo 29
Buffalo 27
Council Bluffs 21
Turin 19
Redwood City 17
Brussels 16
Boardman 15
Guangzhou 15
Ho Chi Minh City 13
Hanoi 12
Nuremberg 12
Shanghai 12
Zhengzhou 12
Nanjing 11
Kunming 10
Tokyo 10
Denver 9
London 9
Redondo Beach 9
Stockholm 9
Chennai 8
Montreal 8
Mülheim 8
Atlanta 7
Brooklyn 7
Chicago 7
Hefei 7
Jinan 7
Manchester 7
Menlo Park 7
Milan 7
Norwalk 7
San Francisco 7
Warsaw 7
Wuhan 7
Helsinki 6
Mountain View 6
Poplar 6
San Mateo 6
Curitiba 5
Falls Church 5
Orem 5
Phoenix 5
Pune 5
Quito 5
Saint Louis 5
Salt Lake City 5
Toronto 5
Utrecht 5
Ankara 4
Biên Hòa 4
Cagliari 4
Cangzhou 4
Casarile 4
Centrale 4
Chengdu 4
Columbus 4
Dhaka 4
Espoo 4
Genoa 4
Guarulhos 4
Hounslow 4
Jakarta 4
Kilburn 4
Nanchang 4
Padova 4
University Park 4
Vancouver 4
Amman 3
Belo Horizonte 3
Bochum 3
Boston 3
Bắc Giang 3
Totale 9.193
Nome #
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 518
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 491
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 470
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 459
IL-21 in the pathogenesis and treatment of skin diseases 426
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 424
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 421
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 393
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 387
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 367
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 365
IL-21, a new player in pathogenesis of psoriasis 335
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 332
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 319
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 314
null 287
Long-term efficacy and safety of adalimumab on a severe case of Hidradenitis Suppurativa 273
Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis 242
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 191
Cutaneous mastocytosis: a dermatological perspective 179
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 169
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: a case series and literature review 165
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 160
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 156
Vulvar basal cell carcinoma, so rare? 146
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 144
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 130
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 130
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis 127
Genetic markers predictive of clinical response to biological drugs in psoriasis. 125
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method 124
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis 124
Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report 124
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 122
Suicide risk and psychiatric comorbidity in patients with psoriasis. 121
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody 119
Nanomedicine in dermatology: Benefits and emerging applications 119
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 118
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 113
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 113
p53 promuove la progressione tumorale nelle cellule di melamona resistenti agli inibitori di BRAF 106
Targeted therapy in nonmelanoma skin cancers 100
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 100
TRIM8 and p53: Making the right decision 98
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) 97
Programmed cell death in the skin 93
Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy 91
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 79
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 75
A Longitudinal Multiinstitutional Study of Vulvar Lichen Sclerosus: From Childhood to Perimenopause 68
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 68
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 67
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 63
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients 60
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy 58
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom 57
Genetic variations in IL6 and IL12B as protective markers for psoriasis 57
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 44
Usefulness of topical imiquimod 3.75% in cytokeratin 7 positive extramammary paget disease of the vulva: towards personalized therapy 43
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 42
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol? 42
Totale 11.350
Categoria #
all - tutte 35.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021823 0 0 0 0 0 188 190 180 68 83 93 21
2021/2022570 23 62 17 23 18 36 45 23 38 53 55 177
2022/2023853 93 82 73 109 56 211 58 43 82 6 32 8
2023/2024316 34 7 19 7 33 95 12 29 4 8 9 59
2024/20251.197 66 244 123 97 13 75 115 58 82 105 80 139
2025/20261.022 180 104 259 231 221 27 0 0 0 0 0 0
Totale 11.350